Cognitive-behaviour therapy for adolescents with body dysmorphic disorder

A pilot randomized controlled trial of cognitive-behaviour therapy for children and adolescents with body dysmorphic disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN67699666

Enrollment

Registered

2012-08-23

Start date

2012-02-15

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorders Mental and Behavioural Disorders Personality disorder, unspecified

Interventions

CBT, Cognitive Behaviour therapy (CBT) designed for young people with BDD, and their families. The current trial involves 14 CBT sessions over 4 months and 4 follow up sessions over 12 months. Follow

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 12 to 18 2. DSM-IV diagnosis of BDD (they may have an additional diagnosis of Delusional Disorder when it refers to beliefs about being ugly or defective) 3. Score of 24 or higher on the 12-item BDDY-BOCS, indicating substantial symptom severity 4. Stable psychotropic medication for 12 weeks prior to randomisation (if relevant) 5. No plans to commence or increase the dose of psychotropic medication (if relevant) 6. Willingness to receive psychological treatment 7. Willingness to be randomised to a waitlist/psychoeducation control condition 8. Willingness/ability to travel to the clinic for CBT 9. Male and female participants 10. Aged between 12 - 18 years

Exclusion criteria

Exclusion criteria: 1. Current or past diagnosis of schizophrenia or bipolar affective disorder, current alcohol or substance dependence, severe disabling neurological disorder, global learning disability, pervasive developmental disorder, or an emerging borderline personality disorder that requires treatment in its own right 2. The patient has suicidal intent that requires hospitalisation 3. English too poor to engage in treatment; characteristics interfering with completion of treatment e.g. selective mutism, lack of motivation, unable to attend clinic.

Design outcomes

Primary

Measure	Time frame
1. The Yale Brown Obsessive Compulsive Scale Modified for BDD Adolescent Version (BDD-YBOCS-A) 2. Admin to all participants at pre, mid, and post-intervention and at 2, 6, and 12 months follow-up.	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 15, 2026